Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hoshi Iryo-Sanki CoTSE:7634 +0.19%75 EBITDA Margin % is 37.10% as of Mar. 2026, which is 95% above its 10-year median of 18.98. GuruFocus rates TSE:7634 with a GF Score™ of 75/100 and a GF Value™ of 円4,737.76 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 119 Medical Distribution companies, Hoshi Iryo-Sanki Co ranks better than 92.44% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Hoshi Iryo-Sanki Co's EBITDA for the
three
months ended in Mar. 2026 was 円1,558 Mil. Hoshi Iryo-Sanki Co's Revenue for the
three
months ended in Mar. 2026 was 円4,199 Mil. Therefore, Hoshi Iryo-Sanki Co's EBITDA margin for the quarter that ended in Mar. 2026 was 37.10%.
Hoshi Iryo-Sanki Co (TSE:7634) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Hoshi Iryo-Sanki Co EBITDA Margin % Related Terms
Hoshi Iryo-Sanki Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Hoshi Iryo-Sanki Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7634 vs MCK, COR, CAH: EBITDA Margin % Comparison
For the Medical Distribution subindustry, Hoshi Iryo-Sanki Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hoshi Iryo-Sanki Co EBITDA Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Hoshi Iryo-Sanki Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Hoshi Iryo-Sanki Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hoshi Iryo-Sanki Co (TSE:7634) has a EBITDA Margin % of 37.10% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hoshi Iryo-Sanki Co and its competitors. This is 95% above median its historical median of 18.98. Over the past decade, Hoshi Iryo-Sanki Co's EBITDA Margin % has ranged from 16.02 to 19.99. According to the industry distribution chart, Hoshi Iryo-Sanki Co ranks #9 out of 119 companies in the Medical Distribution industry, placing it in the top 7.6%.
Is Hoshi Iryo-Sanki Co's EBITDA Margin % too high?
Hoshi Iryo-Sanki Co's current EBITDA Margin % of 37.10% is 95% above median its 10-year median of 18.98. Over the past 10 years, this metric has ranged from a low of 16.02 to a high of 19.99. The Medical Distribution industry median EBITDA Margin % is 4.28. Hoshi Iryo-Sanki Co's value of 37.10% is 766.8% above this industry median. Based on the distribution chart, Hoshi Iryo-Sanki Co ranks #9 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Hoshi Iryo-Sanki Co has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hoshi Iryo-Sanki Co's EBITDA Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Hoshi Iryo-Sanki Co ranks #9 out of 119 companies for EBITDA Margin %. This places Hoshi Iryo-Sanki Co in the top 8% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 4.28. Hoshi Iryo-Sanki Co's value of 37.10% is 766.8% above this benchmark. Historically, Hoshi Iryo-Sanki Co's own EBITDA Margin % has ranged from 16.02 to 19.99 over the past decade. While the company's 10-year median is 18.98 vs. the industry median of 4.28, Hoshi Iryo-Sanki Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.28, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hoshi Iryo-Sanki Co's current EBITDA Margin % of 37.10% is 766.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hoshi Iryo-Sanki Co and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hoshi Iryo-Sanki Co's current EBITDA Margin % is 37.10%, which is 95% above median its own 10-year median of 18.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hoshi Iryo-Sanki Co stock overvalued right now?
Based on GuruFocus' analysis, Hoshi Iryo-Sanki Co (TSE:7634) is currently considered Modestly Overvalued. The stock's GF Value™ is 円4,737.76, compared to a current price of 円5,300.00 — trading 11.9% above its estimated fair value. The current EBITDA Margin % is 37.10%, which is 95% above median its 10-year median of 18.98 and 766.8% above the Medical Distribution industry median of 4.28. Hoshi Iryo-Sanki Co's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Hoshi Iryo-Sanki Co (TSE:7634), the current EBITDA Margin % is 37.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hoshi Iryo-Sanki Co (TSE:7634) Overvalued in 2026?
Based on GuruFocus' analysis, Hoshi Iryo-Sanki Co stock appears to be overvalued.
The current stock price of 円5,300.00 is trading 11.9% above its estimated GF Value™ of 円4,737.76.
GuruFocus considers Hoshi Iryo-Sanki Co to be Modestly Overvalued.
Key valuation signals for TSE:7634:
EBITDA Margin %: 37.10% (95% above median its 10-year median of 18.98)
GF Value™: 円4,737.76 vs. price of 円5,300.00 (11.9% above fair value)
Industry Position: 766.8% above the Medical Distribution median (#9 of 119)
No single metric tells the full story. See the TSE:7634 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hoshi Iryo-Sanki Co Ltd is engaged in the manufacturing and sale of pharmaceutical products. The company offers medical oxygen, nitrous oxide, and others. It is also engaged in the planning, manufacture, sale, maintenance, inspection, and repair of medical instrument equipment for medical gas supply facilities. The company's project service includes the production and supply of medical gas, home care, medical gas maintenance, and others.
75GF Score
Get the complete analysis for TSE:7634
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7634 has been successfully added to your 
